Share Email Print

Proceedings Paper

Feedback-mediated cancer therapy: a FRET-based nanoreporter approach
Author(s): Suproteem K. Sarkar; Yashika Khater; Ashish Kulkarni; Shiladitya Sengupta
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

A theranostic nanoparticle system was developed by integrating a chemotherapeutic agent with an “activatable” fluorescent tracer. The system signals tumor death by monitoring the activity of caspase-3, a product of apoptosis, and can therefore screen the treatment sensitivity of a particular tumor. The polymer nanoparticles (Poly [isobutylene-alt-maleic anhydride]) were formed through reprecipitation and contained paclitaxel, a chemotherapy drug, and fluorescein isothiocyanate, a fluorescent dye. The dye’s fluorescence was quenched through Förster resonance energy transfer (FRET) by a quencher that was connected to the dye by a peptide chain. With sizes ranging from 200-250 nm, the nanoparticles were stable for two weeks. The nanoparticles were tested in vitro with responsive Lewis Lung Carcinoma (LLC) cells and taxane-resistant cells. Upon cell death by paclitaxel exposure, caspase-3 cleaved the peptide chain connecting the dye and the quencher, causing the system to fluoresce. When LLC cells were treated with the system, the nanoreporters fluoresced, but when resistant cells were tested, and when the drug was removed from the system, the nanoreporters did not fluoresce. Since the system screens if a drug can successfully kill a particular tumor, it offers a novel and promising approach to personalized medicine.

Paper Details

Date Published: 27 August 2014
PDF: 8 pages
Proc. SPIE 9166, Biosensing and Nanomedicine VII, 916607 (27 August 2014); doi: 10.1117/12.2061379
Show Author Affiliations
Suproteem K. Sarkar, Conestoga High School (United States)
Brigham and Women's Hospital, Harvard Medical School (United States)
Yashika Khater, Brigham and Women’s Hospital, Harvard Medical School (United States)
Ashish Kulkarni, Brigham and Women’s Hospital, Harvard Medical School (United States)
Shiladitya Sengupta, Brigham and Women’s Hospital, Harvard Medical School (United States)

Published in SPIE Proceedings Vol. 9166:
Biosensing and Nanomedicine VII
Hooman Mohseni; Massoud H. Agahi; Manijeh Razeghi, Editor(s)

© SPIE. Terms of Use
Back to Top
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?